Echinacea, better known as purple coneflower, has received a global attention because of its increasing medicinal value. There is enormous potential for the discovery of new medicinal compounds in this species and an immediate need for techniques to facilitate the production of high quality, chemically consistent plant material for drug development and clinical trials. In vitro tissue culture of Echinacea can play a vital role in the development of novel germplasm, rapid multiplication, and genetic modifications for an enhanced phytochemical production. Recent establishment of liquid culture techniques, large-scale bioreactors, and Agrobacterium-mediated transformation are changing the production parameters of the Echinacea species. This review provides an overview of the recent developments in in vitro technologies and challenges that remain in the Echinacea biotechnology.
How to translate text using browser tools
21 August 2007
Echinacea biotechnology: Challenges and opportunities
Bilal Haider Abbasi,
Praveen K. Saxena,
Susan J. Murch,
Chun-Zhao Liu
ACCESS THE FULL ARTICLE
It is not available for individual sale.
This article is only available to subscribers.
It is not available for individual sale.
It is not available for individual sale.
In Vitro Cellular and Developmental Biology - Plant
Vol. 43 • No. 6
November 2007
Vol. 43 • No. 6
November 2007
Agrobacterium-mediated transformation
Echinacea
phytochemicals
Plant growth regulators
Plant regeneration
somatic embryogenesis